All In Biotech

Drug Trial Radar · NCT02145546

Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation

Last checked: Nov 19, 2026Latest source record: May 23, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

600

Planned (sponsor's estimate)

Start

May 2014

Primary completion

May 2017

Study completion May 2017

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Medtronic (Shanghai) Management Co. Ltd.; Beijing CTSmed Co. Ltd
First posted
May 23, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The current evidences indicate that \~30% patients with sick sinus syndrome(SSS) would develop persistent atrial fibrillation (AF) after a long term pacing therapy. However, the accurate influence of antiarrhythmic drugs on the AF is still not well defined. The purpose of the study is to assess the therapeutic effects of various antiarrhythmic drugs (Amiodarone, Sotalol and Propafenone) on the long term management of AF in SSS patients with AF, including the reduced AF burden (duration and episodes) and persistent AF free survival rate. All patients will be followed up for 12 months.

Conditions

  • Atrial Fibrillation

Interventions

  • AmiodaroneDrug

    Amiodarone: 200mg three times a day for two weeks, then change to 200mg per day for the rest of the study.

  • PropafenoneDrug

    150mg per 8 hours, 3 times per day

  • SotalolDrug

    80mg twice per day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Average AF burden in minutes per dayTime frame: monthly up to 12 months
  2. Persistent AF free survival rateTime frame: monthly up to12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicne

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.